Both in Pharmaceuticals
Johnson & Johnson vs Regeneron Pharmaceuticals
Over the past year JNJ returned +46.7% and REGN returned +44.5%; their daily moves had a correlation of 0.25.
JNJ +46.7% REGN +44.5%Growth of $1, one year, split-adjusted
| Metric | JNJ | REGN |
|---|---|---|
| Price | $273.20 | $927.89 |
| Market cap | $657.68B | $95.99B |
| Today | −0.73% | +13.33% |
| 1 month | +5.6% | +26.3% |
| 6 months | +20.3% | +32.3% |
| Year to date | +32.0% | +20.2% |
| 1 year | +46.4% | +42.1% |
| Revenue growth (YoY) | +5.9% | +36.3% |
| Gross margin | 68.1% | 88.8% |
| Net margin | 0.8% | 38.1% |
| P/E (TTM) | 40.9× | 19.9× |
| Price / sales | 6.6× | 5.7× |
| Net cash | -$27.42B | $6.59B |
| Dividend yield | 1.96% | 0.41% |
| Volatility (60d) | 23.4% | 37.0% |
| Short % of float | 0.7% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).